To demonstrate the beneficial effects of IL-13 in the cerebral ischemia, we employed a mouse model of permanent middle cerebral artery occlusion (pMCAo) with subsequent administration of murine recombinant IL-13. The gene discussed is IL13; the disease is Cerebral ischemia.